These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6875024)

  • 21. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Joffe P; Thomsen HS; Meusel M
    Acad Radiol; 1998 Jul; 5(7):491-502. PubMed ID: 9653466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered disposition and availability of cimetidine in liver cirrhotic patients.
    Gugler R; Müller-Liebenau B; Somogyi A
    Br J Clin Pharmacol; 1982 Sep; 14(3):421-30. PubMed ID: 7126415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
    Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA
    Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moxalactam kinetics during chronic ambulatory peritoneal dialysis.
    Singlas E; Boutron HF; Merdjan H; Brocard JF; Pocheville M; Fries D
    Clin Pharmacol Ther; 1983 Sep; 34(3):403-7. PubMed ID: 6224624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.
    Guay DR; Awni WM; Halstenson CE; Kenny MT; Keane WF; Matzke GR
    Antimicrob Agents Chemother; 1989 Nov; 33(11):2012-5. PubMed ID: 2532874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
    Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
    Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review.
    Janknegt R; Koks CH
    Pharm Weekbl Sci; 1984 Dec; 6(6):229-36. PubMed ID: 6393041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roxithromycin disposition in patients on continuous ambulatory peritoneal dialysis.
    Lam YW; Flaherty JF; Yumena L; Schoenfeld PY; Gambertoglio JG
    J Antimicrob Chemother; 1995 Jul; 36(1):157-63. PubMed ID: 8537262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.
    Somogyi A; Rohner HG; Gugler R
    Clin Pharmacokinet; 1980; 5(1):84-94. PubMed ID: 7363531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.
    Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G; Bonati M
    Eur J Clin Pharmacol; 1986; 31(4):501-4. PubMed ID: 2949981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rebound following hemodialysis of cimetidine and its metabolites.
    Ziemniak JA; Cersosimo RJ; Russo J; Moran DM; Kablitz C; Schentag JJ
    Am J Kidney Dis; 1984 May; 3(6):430-5. PubMed ID: 6720687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
    Pancorbo S; Comty C
    Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intravenous and intraperitoneal ceftazidime in chronic ambulatory peritoneal dialysis.
    Demotes-Mainard F; Vinçon G; Ragnaud JM; Morlat P; Bannwarth B; Dangoumau J
    J Clin Pharmacol; 1993 May; 33(5):475-9. PubMed ID: 8331207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age, disease, and cimetidine disposition in healthy subjects and chronically ill patients.
    Schentag JJ; Cerra FB; Calleri GM; Leising ME; French MA; Bernhard H
    Clin Pharmacol Ther; 1981 Jun; 29(6):737-43. PubMed ID: 7226705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketoconazole kinetics in chronic peritoneal dialysis.
    Johnson RJ; Blair AD; Ahmad S
    Clin Pharmacol Ther; 1985 Mar; 37(3):325-9. PubMed ID: 3971656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.